Short description
Cadex Genomics develops molecular diagnostic tests to guide cancer treatment.
Description
Cadex Genomics develops molecular diagnostic assays to guide cancer treatment using liquid-based technology to provide personalized insight into therapy response using simple blood draws. By combining proven approaches to measuring cell-free DNA with cutting edge technology to improve accuracy and sensitivity, Cadex Genomics provides unique insight into therapy response using simple blood draws. Alibrex (TM) is a blood-based assay, developed to help physicians identify patients who are not responding to drug therapy. The assay is optimized to maximize positive predictive value (PPV) and minimize the number of false non-responders.
Last funding
Nopepepe
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Redwood City, California, United States, North America
Founded on
June 12, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Founders
Bill Haack, Greg Schafer, Patrick Hall